AI-generated summary
This protocol describes a planned randomized, double-blind trial comparing low-level laser therapy at three doses (10, 8, or 4 J/cm2 of 904 nm GaAs laser) against placebo laser, alongside conventional ulcer care, in people with diabetic foot ulcers. The authors report that the trial has not yet produced results and that it is intended to clarify which laser parameters work best. Outcomes will be ulcer area and Wagner classification score.
- Participants
- 80
- Who or what was studied
- Volunteers with diabetic foot ulcers recruited at a physical therapy university clinic
- Wavelengths
- 904 nm
- Limits stated in the abstract
- The abstract describes only a trial protocol, so no outcome data or efficacy findings are reported.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 904 nm
- Energy density (fluence)
- 4 J/cm2
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Low-level laser therapy, Laser, Randomized controlled trial, Dose, Trial registration, Control group. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.